Skip to content

Medi-fASt study: Medication reviews for pharmacies - software-supported and therapy-optimised

Medi-fASt study: Medication reviews for pharmacies - software-supported and therapy-optimised

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00034910
Enrollment
60
Registered
2024-08-21
Start date
2024-04-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participants are pharmacists who are to conduct medication reviews on fictitious patient cases

Interventions

Group 1: Group 1 The participants in group 1 conduct two medication reviews without the medication review tool ‘MediCheck’ and two medication reviews with the medication review tool ‘MediCheck’. Group

Sponsors

Institut für Klinische Pharmazie und Pharmakotherapie der Heinrich-Heine-Universität Düsseldorf
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. German licence to practise as a pharmacist 2. current activity in a community pharmacy 3. no previous establishment of the pharmaceutical service ‘Extended medication counselling for polymedication’ in the respective pharmacy 4. declaration of consent to data protection and participation in written form 5. possession of a PC or laptop with Internet access and possession of the ‘Microsoft Word’ software programme

Exclusion criteria

Exclusion criteria: 1. no German licence to practise as a pharmacist 2. no current activity in a public pharmacy 3. lack of declaration of consent to data protection and/or participation in this study 4. already firmly established above-mentioned pharmaceutical service in the pharmacy 5. not possession of a PC or laptop with internet access and the software programme Microsoft Word

Design outcomes

Primary

MeasureTime frame
Required time

Secondary

MeasureTime frame
Detected drug-related problems

Countries

Germany

Contacts

Public ContactArmin Dabidian

Institut für Klinische Pharmazie und Pharmakotherapie der Heinrich-Heine-Universität Düsseldorf

armin.dabidian@hhu.de+49 211 13 840

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026